A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone-refractory prostate cancer who are refractory to docetaxel

Robert W. Ross, Tomasz M. Beer, Susanna Jacobus, Glenn J. Bubley, Mary Ellen Taplin, Christopher W. Ryan, Jiaoti Huang, William K. Oh

    Research output: Contribution to journalArticlepeer-review

    96 Scopus citations

    Fingerprint

    Dive into the research topics of 'A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone-refractory prostate cancer who are refractory to docetaxel'. Together they form a unique fingerprint.

    Medicine & Life Sciences